TXN and Nephropathy: Furthermore, our recent study demonstrated that HSA-Trx prevents experimental contrast-induced nephropathy and cisplatin nephrotoxicity due to its prolonged anti-oxidative action not only in the extracellular compartment but also inside tubular cells19, 20.